Publications by authors named "Arvin Yang"

Claim this Profile
E
Evolving use of real-world evidence in the regulatory process: a focus on immuno-oncology treatment and outcomes.
John C O'Donnell, T Kim Le, Radu Dobrin, Mitch Higashi, Ashley Pereira, Arvin Yang

Future Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local sustained delivery of bupivacaine HCl from a new castor oil-based nanoemulsion system.
Heni Rachmawati, Yang Aryani Arvin, Sukmadjaja Asyarie, Kusnandar Anggadiredja, Raymond Rubianto Tjandrawinata

Drug Deliv Transl Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Blueprint to Advance Colorectal Cancer Immunotherapies.
Dung T Le, Vanessa M Hubbard-Lucey, Michael A Morse, Christopher R Heery, Andrea Dwyer, Arvin Yang

Cancer Immunol Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Arvin Yang

N Engl J Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
Jeffrey S Weber, Sandra P D'Angelo, David Minor, F Stephen Hodi, Ralf Gutzmer, Arvin S Yang

Lancet Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates.
Francesca Avogadri, Roberta Zappasodi, Arvin Yang, Sadna Budhu, Nicole Malandro

Cancer Immunol Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic correlates of the abscopal effect in a patient with melanoma.
Michael A Postow, Margaret K Callahan, Christopher A Barker, Yoshiya Yamada, Jianda Yuan, Arvin S Yang

N Engl J Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of CTLA-4 and GITR for cancer immunotherapy.
Francesca Avogadri, Jianda Yuan, Arvin Yang, David Schaer, Jedd D Wolchok

Curr Top Microbiol Immunol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune regulatory antibodies: are they the next advance?
Jedd D Wolchok, Arvin S Yang, Jeffrey S Weber

Cancer J· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The history and future of chemotherapy for melanoma.
Arvin S Yang, Paul B Chapman

Hematol Oncol Clin North Am· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral vaccination with vaccinia-expressed tumor antigen and granulocyte macrophage colony-stimulating factor overcomes immunological ignorance to tumor antigen.
Arvin S Yang, Claude E Monken, Edmund C Lattime

Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
Arvin S Yang, Edmund C Lattime

Cancer Res· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis